Zimmer Biomet Holdings Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the med tech and diagnostics equity research team at Needham & Company. With me, we have Zimmer Biomet CEO, Ivan Tornos, Executive Vice President and CFO, Suky Upadhyay, Senior Vice President, Investor Relations and Chief Communications Officer, Kerri Mattox. Instead of a standard presentation, we're going to do a Q&A fireside chat format. If you do have questions that you would like to ask, you could submit them electronically through the Needham conference website or you can feel free to e-mail them to me at [email protected], and I'll do my best to fit them in.
Questions & Answers
So with that, we're going to go straight into the questions. I want to start out with one on the orthopedics market. The recon market, i.e., hips and knees was really strong
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
